Features

Features

Debates, in-depth articles, and surprising profiles from ASH Clinical News

Is MRD Testing Worthwhile in Myeloma?

With the clinically effective treatment regimens now available for myeloma, more patients can achieve deep and sustained responses. The ability to measure minimal residual...

Harnessing the Power of Collaboration

ASH Clinical News spoke with Richard Pazdur, MD, director of the U.S. Food and Drug Administration’s (FDA) Oncology Center of Excellence (OCE), about the...

Pulling Back the Curtain: Eduardo M. Sotomayor, MD

Where did you grow up?  I was blessed to grow up in a small, oceanside town (San Juan de Marcona) in the southern part...

Show Me the Money? Show Us the Data!

How will NIH’s new requirement that federally funded clinical trials report outcomes affect researchers? The merits and cautions of data sharing have long been a...

Uncommon Presentations, Uncommon Cancers

In this column, Beth Faiman, CNP, PhD, reviews the 5th edition of the Textbook of Uncommon Cancer. Have you read any hematology-related books recently? Let...

Should Patients With Myelodysplastic Syndromes Undergo Transplant?

For patients with myelodysplastic syndromes (MDS), hematopoietic cell transplantation (HCT) is the only potentially curative option, but the rates of transplant-related morbidity and mortality...

Pulling Back the Curtain: Hetty Carraway, MD, MBA

In this edition, Hetty Carraway, MD, MBA, talks about keeping medicine close to home and the importance of loving what you do. Dr. Carraway...

Agent Orange and Hematologic Malignancies: The Fog of War Still Hovers

More than 40 years after the Vietnam War, the fog of Agent Orange hangs thick over veterans and those providing their medical care. Aging...

Order Matters: The Art and Science of Myeloma Drug Sequencing

Examining the who, what, when, where, and why of myeloma treatment In 1844, Thomas Alexander Bean, one of the first documented patients with multiple myeloma...

Diversity Evolution

The United States is becoming more diverse. Is the medical education system adapting quickly enough? The need for increased diversity in the medical profession is...
Advertisement

Current Issue

July 2017, Volume 3, Issue 8

This issue features an interview with the FDA's Richard Pazdur, highlights from the 2017 ASCO Annual Meeting, a debate about minimal residual disease in myeloma, and more.